Additional secondary outcomes assessed included serum lipids , laboratory biomarkers of inflammation ( C-reactive protein and interleukin @ ) and oxidative stress ( plasma F@ isoprostanes and isofurans ) , monocyte cytokine production , and predialysis blood pressure .